SEC CIK 1420987
Schoeneck James A
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| FGENview stock → | 39,666 | 2025-06-30 |
| KYNBview stock → | 28,766 | 2023-06-07 |
Position History — KYNB
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — KYNB
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-06-12 | Grant / award (derivative) | 7,000 | $0.00 | 7,000 |
| 2024-06-05 | Grant / award (derivative) | 70,000 | $0.00 | 70,000 |
| 2023-08-10 | Grant / award (derivative) | 10,000 | $0.00 | 10,000 |
| 2023-06-07 | Grant / award (derivative) | 12,666 | $0.00 | 12,666 |
| 2023-06-07 | Grant / award | 8,289 | $0.00 | 28,766 |
| 2023-06-07 | Open-market sale | 7,100 | $18.03 | 73,722 |
| 2022-06-16 | Grant / award (derivative) | 25,684 | $0.00 | 25,684 |
| 2022-06-16 | Grant / award | 15,777 | $0.00 | 20,477 |
| 2021-05-26 | Grant / award (derivative) | 7,800 | $0.00 | 7,800 |
| 2021-05-26 | Grant / award | 4,700 | $0.00 | 14,100 |
| 2021-01-04 | Option exercise (derivative) | 6,000 | $0.00 | 0 |
| 2021-01-04 | Option exercise | 6,000 | $9.78 | 15,400 |
| 2020-08-20 | Option exercise (derivative) | 6,000 | $0.00 | 0 |
| 2020-08-20 | Option exercise | 6,000 | $5.95 | 15,400 |
| 2020-06-04 | Grant / award (derivative) | 7,800 | $0.00 | 7,800 |
| 2020-06-04 | Grant / award | 4,700 | $0.00 | 9,400 |
| 2020-01-06 | Tax withholding | 10,928 | $43.35 | 22,422 |
| 2019-09-18 | Grant / award (derivative) | 97,100 | $0.00 | 97,100 |
| 2019-09-18 | Grant / award | 57,300 | $0.00 | 62,000 |
| 2019-06-05 | Grant / award (derivative) | 7,800 | $0.00 | 7,800 |
| 2019-06-05 | Grant / award | 4,700 | $0.00 | 22,400 |
| 2019-05-28 | Option exercise (derivative) | 12,000 | $0.00 | 0 |
| 2019-05-28 | Option exercise | 12,000 | $3.50 | 17,700 |
| 2019-05-28 | Option exercise | 2,000 | $2.90 | 5,700 |
| 2019-05-07 | Option exercise (derivative) | 2,000 | $0.00 | 2,000 |
| 2019-05-07 | Open-market sale | 500 | $47.69 | 3,700 |
| 2019-05-07 | Open-market sale | 1,500 | $46.80 | 4,200 |
| 2019-05-07 | Option exercise | 2,000 | $2.90 | 5,700 |
| 2019-04-08 | Option exercise (derivative) | 2,000 | $0.00 | 4,000 |
| 2019-04-08 | Option exercise | 2,000 | $2.90 | 29,700 |
| 2019-04-08 | Open-market sale | 2,000 | $52.90 | 27,700 |
| 2019-03-07 | Option exercise (derivative) | 2,000 | $0.00 | 6,000 |
| 2019-03-07 | Option exercise | 2,000 | $2.90 | 29,700 |
| 2019-03-07 | Open-market sale | 380 | $55.23 | 27,700 |
| 2019-03-07 | Open-market sale | 1,620 | $54.62 | 28,080 |
| 2019-02-07 | Option exercise (derivative) | 2,000 | $0.00 | 8,000 |
| 2019-02-07 | Open-market sale | 2,000 | $57.17 | 27,700 |
| 2019-02-07 | Option exercise | 2,000 | $2.90 | 29,700 |
| 2019-01-07 | Option exercise (derivative) | 2,000 | $0.00 | 10,000 |
| 2019-01-07 | Option exercise | 2,000 | $2.90 | 29,700 |
| 2019-01-07 | Open-market sale | 2,000 | $45.90 | 27,700 |
| 2018-10-30 | Option exercise (derivative) | 12,000 | $0.00 | 0 |
| 2018-10-30 | Option exercise (derivative) | 12,000 | $0.00 | 0 |
| 2018-10-30 | Option exercise | 12,000 | $9.78 | 15,700 |
| 2018-10-30 | Option exercise | 12,000 | $18.00 | 27,700 |
| 2018-07-03 | Option exercise (derivative) | 7,639 | $0.00 | 12,000 |
| 2018-07-03 | Option exercise | 7,639 | $2.90 | 11,339 |
| 2018-07-03 | Open-market sale | 7,639 | $65.00 | 3,700 |
| 2018-06-22 | Option exercise (derivative) | 4,361 | $0.00 | 19,639 |
| 2018-06-22 | Option exercise | 4,361 | $2.90 | 8,061 |
| 2018-06-22 | Open-market sale | 4,361 | $65.00 | 3,700 |
| 2018-06-05 | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2018-06-05 | Grant / award | 3,700 | $0.00 | 3,700 |
| 2017-06-07 | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2016-06-08 | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2015-06-03 | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2014-11-13 | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.